A hospital-based study: Risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy


Benbir G., Ozekmekci S., Apaydin H., Delil S., Erginoz E.

CLINICAL NEUROLOGY AND NEUROSURGERY, cilt.108, sa.8, ss.726-732, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 108 Sayı: 8
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1016/j.clineuro.2006.02.002
  • Dergi Adı: CLINICAL NEUROLOGY AND NEUROSURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.726-732
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objectives: Although levodopa (LD) is the gold standard therapy for symptomatic treatment of Parkinson's disease (PD), the chronic use of LD leads to the development of motor complications in almost all patients.